| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 19.893 | 22.672 | 24.727 | 17.345 | 28.328 | 60.591 |
| Total Income - EUR | - | - | 0 | 0 | 28.759 | 32.203 | 32.839 | 30.409 | 31.202 | 63.471 |
| Total Expenses - EUR | - | - | 3.450 | 17.182 | 47.810 | 44.611 | 52.172 | 44.607 | 37.202 | 37.297 |
| Gross Profit/Loss - EUR | - | - | -3.450 | -17.182 | -19.052 | -12.408 | -19.333 | -14.198 | -6.000 | 26.174 |
| Net Profit/Loss - EUR | - | - | -3.450 | -17.182 | -19.257 | -12.632 | -19.581 | -14.502 | -6.312 | 24.270 |
| Employees | - | - | 0 | 2 | 3 | 2 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Ganoderma Kfe S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 18.054 | 14.716 | 11.504 | 22.747 | 6.775 | 3.696 | 2.620 |
| Current Assets | - | - | 986 | 8.344 | 10.502 | 9.239 | 22.580 | 10.112 | 20.223 | 45.076 |
| Inventories | - | - | 0 | 7.020 | 10.039 | 6.753 | 18.494 | 2.021 | 18.307 | 30.308 |
| Receivables | - | - | 400 | 392 | 385 | 377 | 1.536 | 7.733 | 19 | 8.687 |
| Cash | - | - | 586 | 932 | 79 | 2.109 | 2.551 | 358 | 1.897 | 6.081 |
| Shareholders Funds | - | - | -3.406 | -20.526 | -39.385 | -51.271 | -69.552 | -84.271 | -90.327 | -65.553 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 202 | 203 | 202 | 201 |
| Debts | - | - | 4.392 | 12.239 | 35.289 | 45.944 | 92.256 | 81.340 | 97.356 | 99.305 |
| Income in Advance | - | - | 0 | 34.686 | 29.314 | 26.070 | 22.624 | 19.818 | 16.890 | 13.944 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4638 - 4638" | |||||||||
| CAEN Financial Year |
1071
|
|||||||||
Comments - Ganoderma Kfe S.r.l.